Glucocorticoid-induced
osteonecrosis of the femoral head (GC-ONFH)
is a serious bone disease that often affects young individuals. Bone
grafting combined with core decompression is mainly used in the clinic
to treat GC-ONFH. However, the outcome is usually not satisfactory,
as expected. Here, we report an engineered exosome-functionalized
extracellular matrix-mimicking hydrogel for promoting bone repair
in GC-ONFH. Compared with Con-Exo, exosomes secreted by bone marrow
stem cells (BMSCs) in conventional culture medium, the engineered
Li-Exo, exosomes derived from bone marrow stem cells (BMSCs) stimulated
by lithium ions, promoted macrophage M2 polarization while inhibiting
macrophage M1 polarization. Furthermore, inspired by the fact that
hydrogels can serve as desirable carriers of exosomes to facilitate
their release in a sustained manner for improved therapeutic efficiency
and in vivo application, an extracellular matrix (ECM)-mimicking hydrogel
(Lightgel) composed of methacryloylated type I collagen was employed
to incorporate Li-Exo/Con-Exo to construct the Lightgel-Li-Exo hydrogel/Lightgel-Con-Exo
hydrogel. In vitro studies showed that the Lightgel-Li-Exo hydrogel
had the most significant pro-osteogenic and pro-angiogenic activity.
Finally, we evaluated the therapeutic effects of the hydrogel in rat
models of GC-ONFH. As a result, the Lightgel-Li-Exo hydrogel had the
most significant effect on enhancing macrophage M2 polarization, osteogenesis,
and angiogenesis to promote bone repair in GC-ONFH. Taken together,
this novel engineered exosome-functionalized ECM-mimicking hydrogel
could be a promising strategy for osteonecrosis treatment.